In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Definitive Healthcare Corp (NASDAQ: DH) was $5.35 for the day, down -26.21% from the previous closing price of $7.25. In other words, the price has decreased by -$26.21 from its previous closing price. On the day, 5.27 million shares were traded. DH stock price reached its highest trading level at $5.355 during the session, while it also had its lowest trading level at $4.38.
Ratios:
Our analysis of DH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.40. For the most recent quarter (mrq), Quick Ratio is recorded 2.21 and its Current Ratio is at 2.21. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on May-09-24, Downgraded its rating to Equal-Weight and sets its target price to $9 from $11.50 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 24 ’23 when SEA VII Management, LLC sold 6,656 shares for $9.39 per share. The transaction valued at 62,500 led to the insider holds 1,441,657 shares of the business.
SEA VII Management, LLC sold 6,240 shares of DH for $56,846 on May 12 ’23. The Director now owns 1,743,478 shares after completing the transaction at $9.11 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DH now has a Market Capitalization of 630171136 and an Enterprise Value of 1157564672. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.46 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at 4.527 whereas that against EBITDA is 51.345.
Stock Price History:
The Beta on a monthly basis for DH is 1.42, which has changed by -0.2609582 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, DH has reached a high of $12.45, while it has fallen to a 52-week low of $5.53. The 50-Day Moving Average of the stock is -31.43%, while the 200-Day Moving Average is calculated to be -37.28%.
Shares Statistics:
DH traded an average of 500.36K shares per day over the past three months and 385160 shares per day over the past ten days. A total of 116.56M shares are outstanding, with a floating share count of 113.82M. Insiders hold about 3.37% of the company’s shares, while institutions hold 45.43% stake in the company. Shares short for DH as of 1713139200 were 6975482 with a Short Ratio of 13.94, compared to 1710460800 on 4831743. Therefore, it implies a Short% of Shares Outstanding of 6975482 and a Short% of Float of 12.85.
Earnings Estimates
The stock of Definitive Healthcare Corp (DH) is currently in the spotlight, with 12.0 analysts actively rating and assessing its market standing.On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.09 and a low estimate of $0.08, while EPS last year was $0.06. The consensus estimate for the next quarter is $0.09, with high estimates of $0.1 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.38 and $0.34 for the fiscal current year, implying an average EPS of $0.38. EPS for the following year is $0.42, with 11.0 analysts recommending between $0.46 and $0.39.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 12 analysts. It ranges from a high estimate of $64.68M to a low estimate of $63.6M. As of the current estimate, Definitive Healthcare Corp’s year-ago sales were $59.2MFor the next quarter, 12 analysts are estimating revenue of $65.19M. There is a high estimate of $66.56M for the next quarter, whereas the lowest estimate is $63M.
A total of 13 analysts have provided revenue estimates for DH’s current fiscal year. The highest revenue estimate was $268.26M, while the lowest revenue estimate was $264M, resulting in an average revenue estimate of $266.27M. In the same quarter a year ago, actual revenue was $251.41MBased on 12 analysts’ estimates, the company’s revenue will be $286.8M in the next fiscal year. The high estimate is $292.81M and the low estimate is $278.9M.
